Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Acadia Pharmaceuticals (ACAD) Q2 2016 Earnings
ACAD
+0.17%
5
May
Confirmed
Q3 2015
Q4 2015
Q1 2016
Q2 2016
-0.45
-0.42
-0.38
-0.35
Details
Expected EPS
-0.43
Actual EPS
-0.45
Surprise EPS
-0.02
Surprise Percent
+4.65%
Description
Acadia Pharmaceuticals (ACAD) has reported earnings of -0.45 per share for Q2 2016.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login